Affiliation:
1. Department of Pharmacology, Dadasaheb Balpande College of Pharmacy, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, (MS) – 440037,India
Abstract
Coronavirus disease 2019 named COVID-19 caused by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) has been reported in Wuhan city of Hubei Province of China become a
global pandemic. Genomic sequencing of SARS-CoV-2 unveils which showed multiple mutations relative
to SARS-CoV. SARS-CoV-2 showed a very high receptor-binding domain (RBD) affinity towards
the ACE-2 receptor in host cells, similar to SARS. Lack of immediate supervision and diagnostic measures
hurdles prevention and treatment strategies against COVID-19. However, from SARS and MERS
epidemics, WHO launched SOLIDARITY, a strategic and technical advisory group for infection hazards
(STAG-IH) for the regular supervision and alert, which identified the estimated risk of COVID-19 and
recommended the health emergence program to respond COVID-19. This article will briefly review the
rationale history, structural genome with mutation, pathogenesis, preventive measure, and targeted
treatment strategy to handle this pandemic COVID-19.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),Complementary and alternative medicine,Pharmaceutical Science
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献